Sep. 12, 2000

Biotech Background Gives Life to Deal

Throughout the waves of initial public offerings in the past few years, most of the headlines have been swept up by young and much-hyped Internet companies. Taking a steadier and less-profiled course have been biotechnology and medical firms that have emerged from recent, exciting developments in the field. No one knows this better than Cameo Jones, a corporate securities attorney who manages the life sciences and technology group at San Francisco's Pillsbury, Madison & Sutro.